- $910.96m
- $1.08bn
- $199.61m
- 57
- 25
- 29
- 30
Annual income statement for Harrow, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 48.9 | 72.5 | 88.6 | 130 | 200 |
| Cost of Revenue | |||||
| Gross Profit | 34.4 | 54.3 | 63.2 | 90.6 | 150 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 48.5 | 69.8 | 86.7 | 135 | 191 |
| Operating Profit | 0.385 | 2.67 | 1.92 | -5.03 | 8.82 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -3.42 | -17.9 | -14 | -23.7 | -17.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.42 | -18 | -14.1 | -24.4 | -17.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.36 | -18 | -14.1 | -24.4 | -17.5 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.36 | -18.5 | -14.1 | -24.4 | -17.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.121 | -0.71 | -0.637 | -0.625 | -0.486 |